Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 17

Evaluation of the Hydrophilic, Cohesive, and Physical Properties of Eight Hyaluronic Acid Fillers: Clinical Implications of Gel Differentiation [Corrigendum]

Authors Enright KM, Weiner SF, Durairaj KK , Gilardino MS, Nikolis A 

Received 22 January 2024

Accepted for publication 22 January 2024

Published 23 January 2024 Volume 2024:17 Pages 173—174

DOI https://doi.org/10.2147/CCID.S460832



Enright KM, Weiner SF, Durairaj KK, Gilardino MS, Nikolis A. Clin Cosmet Investig Dermatol. 2024;17:89-101.

Page 93, Results, Hydrating HA section, first sentence, the text “Restylane-L (HAREST), Restylane Skinboosters Vital Light (HASBVL), Restylane Skinboosters Vital (HASBV), Restylane Lyft (HAL) (Figure 1, parts A-D)” should read “Restylane-L (HAREST), Restylane Skinboosters Vital Light (HASBVL), and Restylane Skinboosters Vital (HASBV) (Figure 1, parts A-C)”.

Page 93, Results, Hydrating HA section, third sentence, the text “The fillers that did expand (swell) as they bound water included HAL, Restylane Defyne (HAD), Restylane Volume (HAV), Restylane Kysse (HAK), and Restylane Refyne (HAR) (Figure 1, parts E-H)” should read “The fillers that did expand (swell) as they bound water included Restylane Lyft (HAL), Restylane Defyne (HAD), Restylane Volume (HAV), Restylane Kysse (HAK), and Restylane Refyne (HAR) (Figure 1, parts D-H)”.

The authors apologize for these errors.


Read the original article


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.